<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The purpose of this study was to explore the significance of abnormal karyotype in diagnosis and prognosis estimation of <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>Chromosome analysis were performed in 306 cases of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> using the short-term culture of bone marrow cell and G-banding technique, and in partial cases FISH technique was used for this analysis </plain></SENT>
<SENT sid="2" pm="."><plain>93 out of 306 cases were followed up </plain></SENT>
<SENT sid="3" pm="."><plain>The results showed that 144 cases (47.1%) had clonal chromosome aberrations </plain></SENT>
<SENT sid="4" pm="."><plain>The most common chromosomal aberrations included +8, translocation, complex or high complex karyotype, -7/7q-, 20q-/-20, <z:mp ids='MP_0004027'>trisomy</z:mp> 1 or partial <z:mp ids='MP_0004027'>trisomy</z:mp> 1, +11/+11q-, -9/9q-, +9/9q+, -Y, dup(1q), +21 </plain></SENT>
<SENT sid="5" pm="."><plain>The rate of abnormal karyotype in <z:hpo ids='HP_0005505'>refractory anemia</z:hpo> with erythroblasts (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e>) and <z:hpo ids='HP_0005505'>refractory anemia</z:hpo> with erythroblasts-transformation (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEBT</z:e>) were much higher than in <z:hpo ids='HP_0005505'>refractory anemia</z:hpo> (RA) and <z:hpo ids='HP_0005505'>refractory anemia</z:hpo> with sideroblasts (<z:mp ids='MP_0011356'>RAS</z:mp>) (P &lt; 0.05) </plain></SENT>
<SENT sid="6" pm="."><plain>The rate of abnormal karyotype among those cases with <z:chebi fb="1" ids="25435">mutagen</z:chebi> contact history were higher than those in cases without <z:chebi fb="1" ids="25435">mutagen</z:chebi> contact history </plain></SENT>
<SENT sid="7" pm="."><plain>The patients with abnormal karyotype had a mean survival time much shorter than patients with <z:mpath ids='MPATH_458'>normal</z:mpath> karyotype (P &lt; 0.005) and had a higher risk transforming into <z:hpo ids='HP_0002488'>acute leukemia</z:hpo> (P &lt; 0.05) </plain></SENT>
<SENT sid="8" pm="."><plain>The worst outcome was observed in those patients with a complex or high complex karyotype, -7/7q- and <z:mp ids='MP_0004027'>trisomy</z:mp> 11 </plain></SENT>
<SENT sid="9" pm="."><plain>In conclusion, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> is highly <z:hpo ids='HP_0001425'>heterogeneous</z:hpo> disorders and karyotype analysis is helpful for its diagnosis, treatment selection and prognosis estimation </plain></SENT>
</text></document>